Isoniazid Mono-Resistant Tuberculosis: Impact on Treatment Outcome and Survival of Pulmonary Tuberculosis Patients in Southern Mexico 1995-2010

BACKGROUND: Isoniazid mono-resistance (IMR) is the most common form of mono-resistance; its world prevalence is estimated to range between 0.0 to 9.5% globally. There is no consensus on how these patients should be treated. OBJECTIVE: To describe the impact of IMR tuberculosis (TB) on treatment outc...

Descripción completa

Detalles Bibliográficos
Autores principales: Báez-Saldaña, Renata, Delgado-Sánchez, Guadalupe, García-García, Lourdes, Cruz-Hervert, Luis Pablo, Montesinos-Castillo, Marlene, Ferreyra-Reyes, Leticia, Bobadilla-del-Valle, Miriam, Canizales-Quintero, Sergio, Ferreira-Guerrero, Elizabeth, Téllez-Vázquez, Norma, Montero-Campos, Rogelio, Yanes-Lane, Mercedes, Mongua-Rodriguez, Norma, Martínez-Gamboa, Rosa Areli, Sifuentes-Osornio, José, Ponce-de-León, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193431/
https://www.ncbi.nlm.nih.gov/pubmed/28030600
http://dx.doi.org/10.1371/journal.pone.0168955

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5193431/
https://www.ncbi.nlm.nih.gov/pubmed/28030600
http://dx.doi.org/10.1371/journal.pone.0168955

Ejemplares similares